The world of artificial intelligence (AI) and robotics has evolved and continues to become more widely used, and the medical industry represents one of its most promising applications. Scientists at the University of Bern’s Center for Biomedical Engineering Research have already found a way to carry out robot-assisted cochlear implantation, which is one of many examples. But while robotic surgery is an exciting technological breakthrough, it poses some moral dilemmas and practical challenges, and those overseeing the developments in the OR need to play a role in addressing them.
When humans and robots become ‘coworkers,’ where does the blame lie when something goes wrong? Does this line of questioning complicate relations between device manufacturers and surgeons? And will society ever trust robots enough to carry out risky surgeries or make decisions without human supervision? These are difficult questions, and those in the sector will want to be sure these concerns have been aired before they heavily invest in robotics.
Trust will always be an inherent part of robotics. On a basic level, we need to trust robot manufacturers enough to use the devices they produce. In the OR, there are a few more levels to this.
There must be trust in the business relationships between vendors and healthcare providers to mitigate concerns about safety and quality. This must then be transferred from decision makers to surgeons and from surgeons to patients. Most patients have limited technical and medical knowledge about these devices and may be less trusting. Providers play an important role in mitigating that by educating and reassuring patients about robots—for instance, by clarifying the roles of the surgeon versus the robot and how they work together, as well as the benefits the robot brings to the table.
Robotics and AI have sometimes been met with skepticism by the general public due to stigma and sensationalism. Countless stories have been crafted about AI disastrously turning against humanity. It is one thing for something as benign as getting a robot to clean a house, but for a device to maybe hold responsibility over what happens in the OR is an entirely different ball game.
“I think there are some in the population who have a distrust of robots and machines in general,” says T. Sloane Guy, MD, MBA, clinical director of cardiac surgery at Thomas Jefferson University Hospital in Philadelphia. “But just like with autonomous vehicles, while there have been problems, the overall rate of problems is lower than that driven by human hands. There will always be some doubt, but I think trust will increase with time.”
Some think that shift has begun already. “I’ve never had a patient say no to the use of a robot,” says Ankit D. Patel, MD, FACS, associate professor of surgery at Emory University School of Medicine in Atlanta, Georgia. “We are a massive referral facility for robotic procedures, and patients come to us from all over the world, especially for cardiac.” However, Dr Patel does wonder if this could change as the technology develops, especially if and when we reach the point of performing surgery without human intervention. “It’s important to prepare for that possibility,” he adds.
Healthcare providers can facilitate conversations about new robotic devices in a way that inspires trust and confidence in their patients, such as comparing the experience of surgery with and without robots. The relationship between providers and vendors may be even more important than communication between patients and providers because vendor cooperation is needed for
robots to become a success—and they play a role in educating the public too. All three experts interviewed agree that trust among surgeons is high. “I do not believe there is an issue of lack of trust of the actual devices,” says Dr Patel. “The da Vinci system has been around for 20 plus years now, and the device has been validated.”
Ben Merick, vice president of operations at Mercy Health, Springfield Regional Medical Center, Ohio, points out that “robotic surgeries are significantly better for providers” because they allow surgeons to sit rather than stand and use consoles instead of hold instruments. Similarly, nursing robots may be also able to ease the burden for nurses and surgical technologists in the OR by performing tasks such as holding instruments and transporting specimens.
One of the biggest issues in the use of robotics in surgery is its liability. Is the hospital always at fault? Is there a case for blaming the manufacturer or even the programmer? How can we prepare for possible gray-area outcomes?
“Ultimately, the surgeon is always responsible,” says Dr Guy. However, there are exceptions when it comes to mechanical problems with the robot, and it is crucial for OR managers to train staff and develop internal procedures for all scenarios, he adds.
Fortunately, the general public may be exaggerating the risks involved with using robots relative to the risks of surgeons performing these procedures themselves.
“Most ‘mistakes’ made during surgery are user errors or from problems related to the procedure,” says Dr Patel. “Like any other medical device, there are occasional issues with the robot that may cause inadvertent complications like misapplication of energy or device failures during surgery.”
He echoes Dr Guy by pointing to protocols as the solution. “This is why societies like SAGES [Society of American Gastrointestinal and Endoscopic Surgeons] emphasize proper training to use these devices,” he says. “At our institution, all cases are recorded for quality control, and if there is an issue during a case, we can review and analyze the problem. We also work closely with the device manufacturers to look at their data to see if there are opportunities to improve or avoid these types of issues.”
When discussing trust, it is important to remember that OR scenarios involving robots can differ greatly depending on the type of procedure and the robot used.
On one end of the spectrum, we have robotic heart surgery, in which robot-controlled tools with cameras assist surgeons in less invasive procedures. Recently, the University of California San Francisco carried out its first mitral valve surgery using robotic assistance. It is a major breakthrough, but decision makers need to make sure there is a sufficient level of trust among surgeons and patients for such a crucial procedure.
On the other hand, minor operations might not require as extensive decision-making capabilities and trust-building exercises, but assessments are still necessary. For instance, Vicarious Surgical has developed an upper-body-shaped robot that uses decoupled actuators for minimally invasive surgery.
Other major machines being used in the OR at the moment include:
• Mazor X: Used for minimally invasive spine surgery.
• Stryker Mako: Used for orthopedic procedures.
• Brainlab Suite: Used for minimally invasive surgery, spine surgery, and neurosurgical procedures.
One big question mark around the use of robots is whether they are too expensive. Since robotic surgery mostly relies on surgeons to interact with AI to control the robots during procedures, the investment cannot—and should not—be offset by reducing surgeon/staff wages. Instead, hospitals and other facilities have to properly invest in both.
And even if the paremeters existed for surgical robots to safely work autonomously, this would still be costly. A surgical robot today costs around $2 million. Before robotics are mainstream for surgical applications, the cost issue must be remedied.
“I find the hesitancy for robot adoption comes down to operational efficiency and financial performance,” Merick says. “These tools and outcomes are still not recognized by payers for the advantages of higher levels of minimally invasive surgery.”
Robotics can mean swifter recoveries and also make surgical procedures better for surgeons and OR staff. Investment and trust are inherently linked—the more providers and patients trust the technology, the more investment there will be in the industry, which will help increase trust overall. “Having the best tools available does factor into patients’ decisions. For example, a Mako knee replacement can be seen as more desirable due to recovery time and outcome,” says Merick.
Big data will also help to boost efficiency by crunching the numbers and figures on different outcomes in the OR and figuring out the best ways robots can react to different circumstances.
“In my subspecialty of robotic cardiac surgery, it is basically cost neutral because the increased cost of robotic instrumentation in the OR is offset by earlier discharge from the hospital,” Dr Guy points out. “This has been confirmed by Cleveland Clinic and Mayo Clinic, as well as other institutions.” As this becomes more widely acknowledged, and if it is found to also apply to other specialties, the hesitancy when considering costs could start to change.
This also benefits hospitals as they would have the capacity to take on more patients. One 2020 study from the NHS Grampian in the UK predicted: “We would anticipate that the length of stay reduction achieved with the shift to robotic surgery…would release capacity for an additional 72 general surgery procedures per annum.”
Decision makers have a lot on their plates as they prepare for robotics to become a bigger part of the OR. Those interviewed agree that decision makers do not need to be too worried about healthcare providers because they seem to have a lot of trust in robotics.
However, this could change in the future if providers become fearful of the blame falling on them when something goes wrong. To prevent this from happening, decision makers must facilitate strong communication between vendors and OR staff and ensure that the right training and protocols are being implemented. This could translate into patients and the general public having more trust in AI, although there may always be an element of natural distrust in robotic surgery due to the innate lack of humanity.
For now, the most significant obstacle is the cost of having robotic technology and reassuring healthcare leaders that the technology will save more than it costs in the long run. Increased trust may be the key to promoting more innovation and technological development. As technology continues to advance, hospitals and other facilities need to establish trust in robotics by advertising the benefits robots can bring to patients and healthcare workers alike.
—David Cotriss is an award-winning writer who has covered business, technology, and finance for over 30 years and has published with The Economist, CNBC, Engineering360, and Entrepeneur
Krigel M. UCSF performs first robotic cardiac surgery. UCSF News. July 13, 2022.